Zeidan, A., Diez-Campelo, M., Santini, V., Buckstein, R., Adès, L., Sahagun, L., Das, G., Zelinsky, T., Lai, Y., Miteva, D., McBride, A., Nadal, J. A., Madry, K., Valcárcel, D., Diaz, J. M. T., Deeren, D., Grosicki, S., Venugopal, S., Platzbecker, U., Porta, M. D. (2025). Luspatercept initiated at the maximum-approved dose in transfusion-dependent lower-risk myelodysplastic syndromes: Interim analysis from maxilus. Blood. https://doi.org/10.1182/blood-2025-789